Literature DB >> 18973229

Risk of contralateral testicular cancer among men with unilaterally undescended testis: a meta analysis.

Olof Akre1, Andreas Pettersson, Lorenzo Richiardi.   

Abstract

The association between undescended testis (cryptorchidism) and testicular cancer is established, but it is not known whether the risk of testicular cancer among men with unilateral maldescent is increased in both testes, or only on the undescended side. This is a meta-analysis of 11 case-control studies and 1 cohort study that all assessed the risk of testicular cancer separately for the undescended and descended testis. We used fixed-effects meta-analysis to calculate pooled estimates and 95% confidence intervals (CIs) for the relative risk. Of 199 tumors in men with unilateral cryptorchidism, 158 (79%) were on the ipsilateral side and 41 (21%) on the contralateral side. The pooled relative risks for testicular cancer in the ipsilateral and contralateral testis were 6.33 (95% CI, 4.30 to 9.31) and 1.74 (95% CI, 1.01 to 2.98), respectively. We conclude that in 1-sided undescended testis, the risk of testicular cancer may be increased in both testes, although to a much greater extent on the ipsilateral side. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 18973229     DOI: 10.1002/ijc.23936

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  Pharmacologic and Environmental Endocrine Disruptors in the Pathogenesis of Hypospadias: a Review.

Authors:  Rajiv Raghavan; Megan E Romano; Margaret R Karagas; Frank J Penna
Journal:  Curr Environ Health Rep       Date:  2018-12

Review 2.  Cryptorchidism: A practical review for all community healthcare providers.

Authors:  Luis H Braga; Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

3.  Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.

Authors:  Delphine Carouge; Valerie Blanc; Sue E Knoblaugh; Robert J Hunter; Nicholas O Davidson; Joseph H Nadeau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-31       Impact factor: 11.205

4.  Canadian Urological Association-Pediatric Urologists of Canada (CUA-PUC) guideline for the diagnosis, management, and followup of cryptorchidism.

Authors:  Luis H Braga; Armando J Lorenzo; Rodrigo L P Romao
Journal:  Can Urol Assoc J       Date:  2017-07-11       Impact factor: 1.862

Review 5.  Risk factors for cryptorchidism.

Authors:  Jason K Gurney; Katherine A McGlynn; James Stanley; Tony Merriman; Virginia Signal; Caroline Shaw; Richard Edwards; Lorenzo Richiardi; John Hutson; Diana Sarfati
Journal:  Nat Rev Urol       Date:  2017-06-27       Impact factor: 14.432

Review 6.  Clinical stage I seminoma: the case for surveillance.

Authors:  Nathan Lawrentschuk; Neil Fleshner
Journal:  World J Urol       Date:  2009-06-11       Impact factor: 4.226

7.  Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options.

Authors:  Michael C Risk; Timothy A Masterson
Journal:  Indian J Urol       Date:  2010 Jan-Mar

8.  Examination under anesthesia for management of impalpable undescended testis: a traditional technique revisited.

Authors:  Ossama M Zakaria; Emad Hokkam; Karam E El Kadi; Waleed H Al Buali; Hazem M Zakaria; Mohamed Y Daoud; Sameh A Shehata; Abdulrahman S Almulhim; Hamed A Alwadaani
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

Review 9.  Transitional Urology for Male Adolescents: What Adult Urologists Should Know.

Authors:  Kristina D Suson
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

10.  Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics.

Authors:  Kimberly Banks; Ellenie Tuazon; Kiros Berhane; Chester J Koh; Roger E De Filippo; Andy Chang; Steve S Kim; Siamak Daneshmand; Carol Davis-Dao; Juan P Lewinger; Leslie Bernstein; Victoria K Cortessis
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.